Literature DB >> 15146120

In vitro and in vivo assays of B-lymphocyte migration.

Chantal Moratz1, John H Kehrl.   

Abstract

The development and functional activities of B lymphocytes critically depend on their migratory capacity. Both in vitro and in vivo assays can be used to assess the migratory ability of B cells. Filter-based transwell assays measure both spontaneous and chemoattractant-induced cell migration in vitro. Flow cytometric analysis of labeled cell subsets present in the input and migratory cells from transwell assays allows the assessment of the migratory capacity of specific cell types in a complex mixture of cells. A similar approach can be used to assess the migratory capacity of B cells transfected with a green fluorescent fusion protein. Despite the success of the transwell assay, attempts to image directionally migrating B cells have been limited. The assessment of the in vivo migratory capacity of genetically modified or pharmacologically treated B cells usually involves their adoptive transfer into recipient mice. The localization of transferred cells in lymphoid organs can be determined by immunohistochemistry and/or flow cytometric analysis of harvested tissues or cells. Because the proper localization of B cells in lymphoid organs is a multistep process, abnormal positioning can occur even in the absence of an intrinsic defect in cell migration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146120     DOI: 10.1385/1-59259-796-3:161

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  In vitro characterization of chemokine-loaded liposomes.

Authors:  Angel J Rubio; Xuemei Zhong; Tyrone M Porter
Journal:  Cogent Biol       Date:  2019-09-11

2.  Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.

Authors:  John H Wang; Jun Li; Qi Wu; PingAr Yang; Rahul D Pawar; Shutao Xie; Laura Timares; Chander Raman; David D Chaplin; Lu Lu; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

3.  Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine.

Authors:  Kyp L Oxley; Brett M Hanson; Ashley N Zani; Gail A Bishop
Journal:  Cancer Immunol Immunother       Date:  2021-03-25       Impact factor: 6.630

4.  Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.

Authors:  Sheng-Huei Yang; Chien-Feng Li; Pei-Yi Chu; Hsiu-Hsing Ko; Li-Tzong Chen; Wan-Wen Chen; Chia-Hung Han; Jr-Hau Lung; Neng-Yao Shih
Journal:  Oncotarget       Date:  2016-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.